Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
B-WYN-PLUS
- Development stage
- Unknown
- Lead developer
- Garwyn Remedies
- Modality
- Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
B-WYN-PLUS is an oral combination syrup developed by Garwyn Remedies, formulated to support liver health and function. It contains silymarin, L-ornithine L-aspartate, tricholine citrate, and vitamin B complex. Silymarin provides antioxidant and anti-inflammatory properties to protect liver cells from toxins, while L-ornithine and L-aspartate assist in ammonia detoxification via the urea cycle. Tricholine citrate acts as a lipotropic agent to prevent fat accumulation in the liver, and the B-complex vitamins support cellular energy metabolism and overall hepatic recovery. B-WYN-PLUS is primarily indicated as a liver tonic for conditions such as fatty liver, hepatitis, and liver cirrhosis.
- Brand names
- B-WYN-PLUSB-WYN-PLUS Syrup
- Other names
- silymarin + l-ornithine l-aspartate + tricholine citrate + B-complexsilymarin + l-ornithine l-aspartate + tricholine citrate + vitamin B complex
Beyond the preview
Go deeper on B-WYN-PLUS.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on B-WYN-PLUS.